Faecalibacterium prausnitzii and ME/CFS: what the viral claim gets wrong

A clear fact-check of the viral claim that a Leiden study cured ME/CFS by restoring Faecalibacterium prausnitzii, and what science actually says.

Published on

Illustration of gut bacteria, a research paper, and a fact-check symbol about ME/CFS claims

A viral Facebook post claimed that Dutch researchers at Leiden University Medical Center had found a gut bacterium that could largely resolve ME/CFS. That would be huge news. But after checking the scientific literature, the central claim does not hold up.

The short version

Here is what appears to be true.

Faecalibacterium prausnitzii is a real gut bacterium. It is widely studied because it helps produce butyrate, a short-chain fatty acid linked to gut barrier support and anti-inflammatory effects.

People with ME/CFS have been reported in major 2023 papers to have lower levels of butyrate-producing gut bacteria, including F. prausnitzii. That is a real signal.

What does not appear to exist is the specific 2024 Leiden study described in the viral post, the claimed targeted probiotic trial, or the claim that restoring this bacterium led to complete resolution of fatigue, brain fog, and post-exertional malaise in most participants.

What the viral post claimed

The post attributed a major breakthrough to Leiden University Medical Center and to the journal Cell Host & Microbe in 2024. It said researchers had identified a specific depleted strain of F. prausnitzii in ME/CFS, restored it with a targeted probiotic therapy, and achieved complete symptom resolution in a majority of trial participants.

That is the kind of claim that should leave a clear scientific trail: named authors, a paper, a DOI, a trial record, and reporting by the institution itself.

That trail could not be found.

What the science actually says about F. prausnitzii

There is a real scientific basis behind part of the story, which is probably why the false claim sounded plausible.

It is often described as anti-inflammatory

A landmark 2008 paper identified F. prausnitzii as an anti-inflammatory commensal bacterium in the context of Crohn’s disease research. Later work suggested that both the bacterium itself and substances it produces may influence inflammatory pathways.

It helps produce butyrate

Butyrate is a molecule made by some gut bacteria when they ferment dietary fibers. It matters because it can help nourish cells in the colon, support the intestinal barrier, and influence immune activity.

This does not mean one bacterium is a magic switch for complex chronic illness. It means the bacterium is part of a larger gut ecosystem that may matter.

It is difficult to turn into a simple probiotic

This point matters a lot. F. prausnitzii is highly oxygen-sensitive. In plain language, it is hard to grow, stabilize, transport, and deliver as a standard probiotic product. Scientists are working on that problem, but it is precisely the sort of detail that makes the “they restored it and most patients recovered” story look even less credible.

What has really been found in ME/CFS

Two important papers published on 8 February 2023 in Cell Host & Microbe reported that people with ME/CFS showed changes in the gut microbiome, including reduced butyrate-producing capacity and lower levels of bacteria such as F. prausnitzii.

One of those studies also found that lower abundance of F. prausnitzii was associated with greater fatigue severity.

That is important. But it is still an association. It does not prove that this bacterium is the root cause of ME/CFS, and it does not prove that restoring it would cure the disease.

This is where many viral health posts go off the rails: they take a real signal and inflate it into a proven cure.

Could it still matter for Long Covid or ME/CFS?

Yes, as a research direction. No, as a proven cure.

For ME/CFS, the microbiome is a serious area of investigation. Lower levels of butyrate-producing bacteria may matter for inflammation, gut permeability, immune signaling, and symptom burden. But the field is still trying to separate cause from consequence.

That distinction is crucial. A bacterium can be low because it contributes to illness, because illness changes diet and activity, or because both processes feed each other.

For Long Covid, the microbiome story is also active. Some studies have reported lower levels of beneficial bacteria, including F. prausnitzii, in people with persistent symptoms. There has even been a randomized placebo-controlled trial of a synbiotic called SIM01 in post-acute COVID syndrome, with improvements reported in some symptoms. But that was not a single-bacterium cure, and it did not show universal or complete recovery.

So the sensible conclusion is this: microbiome support may become part of future treatment strategies, but the evidence is nowhere near “one missing bacterium was restored and most patients were cured.”

So was the Facebook post false?

On the core point, yes: it appears false.

There is solid evidence that F. prausnitzii is biologically interesting, often reduced in ME/CFS, and plausibly relevant to inflammation and gut function. But the specific breakthrough story in the viral post does not match the published record that could be verified.

That does not prove with absolute certainty that an unpublished internal study never existed. But when a post names a major institution, a journal, a year, and dramatic clinical outcomes, and none of that can be traced in the normal scientific record, skepticism is not cynicism. It is basic hygiene.

Was it likely AI-generated or AI-hallucinated?

It is possible, and the pattern fits.

The post blends real ingredients with invented conclusions:

  • real bacterium
  • real anti-inflammatory discussion
  • real ME/CFS microbiome papers
  • invented study attribution
  • invented intervention
  • invented level of clinical success

That is exactly how many AI-generated misinformation posts read: they are not random nonsense, they are polished composites of truth and fabrication.

Whether a human wrote it carelessly, an AI wrote it, or a human used AI and failed to verify it, the practical conclusion is the same: it should not be trusted as a scientific source.

What readers should retain

A useful way to remember this story is simple.

The gut microbiome may be one piece of the ME/CFS and Long Covid puzzle.

F. prausnitzii is a serious bacterium in research, not a joke and not an invention.

But a real scientific lead is not the same thing as a proven therapy.

When a post jumps from “researchers found a correlation” to “scientists found the cause and cured most patients,” something has usually gone wrong.

Sources

Back to all articles

Back to top